Funding for this research was provided by:
Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research Grant B in 2012; Grant No. 24701038)
Received: 12 April 2020
Accepted: 10 May 2021
First Online: 22 May 2021
: This trial was approved by the institutional review boards of Toranomon Hospital and Tokyo Medical and Dental University. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review boards and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.Written informed consent was obtained from all individual participants included in the study.This article does not contain any studies with animals performed by any of the authors.
: Not applicable.
: TT has received honoraria from Daiichi-Sankyo, Kyowa Kirin, Eisai, Pfizer, and Eli Lilly; and research funding from Daiichi-Sankyo, Kyowa Kirin, Eisai, Chugai, Taiho, Novartis, Ono, Bristol-Myers Squibb, MSD, and Merck Serono. All remaining authors have nothing to disclose.